scholarly journals A very-low-protein diet ameliorates advanced diabetic nephropathy through autophagy induction by suppression of the mTORC1 pathway in Wistar fatty rats, an animal model of type 2 diabetes and obesity

Diabetologia ◽  
2016 ◽  
Vol 59 (6) ◽  
pp. 1307-1317 ◽  
Author(s):  
Munehiro Kitada ◽  
Yoshio Ogura ◽  
Taeko Suzuki ◽  
Shi Sen ◽  
Seon Myeong Lee ◽  
...  
2017 ◽  
Vol 119 (1) ◽  
pp. 22-29 ◽  
Author(s):  
Dongmei Liu ◽  
Ming Wu ◽  
Lin Li ◽  
Xiang Gao ◽  
Bo Yang ◽  
...  

AbstractDiabetic nephropathy (DN) is a major cause of chronic kidney disease. We aimed to investigate the effect of the low-protein diets (LPD) supplemented with ketoacids (LPD+KA) in KKAy mice, an early type 2 DN model. KKAy mice were treated with normal protein diet (NPD), LPD or LPD+KA from 12 to 24 weeks of age. A period of 12-week treatment with LPD significantly reduced albuminuria as compared with that observed after NPD treatment. Treatment with LPD+KA further reduced albuminuria as compared with that observed with LPD treatment alone. Moreover, LPD treatment reduced mesangial expansion, thickness of glomerular basement membrane and the severity of the podocyte foot process effacement in KKAy mice; these effects were more pronounced in KKAy mice treated with LPD+KA. Both LPD and LPD+KA treatments slightly reduced total body weight, but had no significant effect on kidney weight and blood glucose concentrations when compared with NPD-treated KKAy mice. LPD treatment slightly attenuated oxidative stress in kidneys as compared with that observed in NPD-treated KKAy mice; however, LPD+KA treatment remarkably ameliorated oxidative stress in diabetic kidneys as shown by decreased malondialdehyde concentrations, protein carbonylation, nitrotyrosine expression and increased superoxide dismutase expression. Nutritional therapy using LPD+KA confers additional renal benefits as compared with those of LPD treatment alone in early type 2 DN through inhibition of oxidative stress.


2005 ◽  
Vol 15 (4) ◽  
pp. 398-406 ◽  
Author(s):  
Bertrand Dussol ◽  
Cecilia Iovanna ◽  
Denis Raccah ◽  
Patrice Darmon ◽  
Sophie Morange ◽  
...  

2020 ◽  
Vol 319 (4) ◽  
pp. R485-R496 ◽  
Author(s):  
Emilyn U. Alejandro ◽  
Seokwon Jo ◽  
Brian Akhaphong ◽  
Pau Romaguera Llacer ◽  
Maya Gianchandani ◽  
...  

Maternal low-protein diet (LP) throughout gestation affects pancreatic β-cell fraction of the offspring at birth, thus increasing their susceptibility to metabolic dysfunction and type 2 diabetes in adulthood. The present study sought to strictly examine the effects of LP during the last week of gestation (LP12.5) alone as a developmental window for β-cell programming and metabolic dysfunction in adulthood. Islet morphology analysis revealed normal β-cell fraction in LP12.5 newborns. Normal glucose tolerance was observed in 6- to 8-wk-old male and female LP12.5 offspring. However, male LP12.5 offspring displayed glucose intolerance and reduced insulin sensitivity associated with β-cell dysfunction with aging. High-fat diet exposure of metabolically normal 12-wk-old male LP12.5 induced glucose intolerance due to increased body weight, insulin resistance, and insufficient β-cell mass adaptation despite higher insulin secretion. Assessment of epigenetic mechanisms through microRNAs (miRs) by a real-time PCR-based microarray in islets revealed elevation in miRs that regulate insulin secretion (miRs 342, 143), insulin resistance (miR143), and obesity (miR219). In the islets, overexpression of miR143 reduced insulin secretion in response to glucose. In contrast to the model of LP exposure throughout pregnancy, islet protein levels of mTOR and pancreatic and duodenal homeobox 1 were normal in LP12.5 islets. Collectively, these data suggest that LP diet during the last week of pregnancy is critical and sufficient to induce specific and distinct developmental programming effects of tissues that control glucose homeostasis, thus causing permanent changes in specific set of microRNAs that may contribute to the overall vulnerability of the offspring to obesity, insulin resistance, and type 2 diabetes.


2007 ◽  
Vol 21 (6) ◽  
Author(s):  
Viktor R. Drel ◽  
Nazar Mashtalir ◽  
Olga Ilnytska ◽  
Valeryi V. Lyzogubov ◽  
Fei Li ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document